A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Kenya, Africa.
Phase of Trial: Phase I/II
Latest Information Update: 06 Aug 2010
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 06 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.